ClassID:

170676

G01N2333/968 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on peptide bonds (3.4) Plasmin, i.e. fibrinolysin

Recent Application in this class:
#1
20250138031
2025-05-01

IN VITRO MEASUREMENT OF THE LYSIS OF A FIBRIN CLOT

#2
20240360492
2024-10-31

COAGULATION AND FIBRINOLYSIS ASSAYS

#3
20240288446
2024-08-29

METHOD FOR DIAGNOSING FIBRINOLYTIC INSUFFICIENCY RELATED TO NEUTROPHIL EXTRACELLULAR TRAPS

#4
20220187303
2022-06-16

Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease

#5
20210189487
2021-06-24

METHOD FOR SCREENING AGENTS PROMOTING SKIN BARRIER FUNCTION AND METHOD FOR EVALUATING SKIN BARRIER FUNCTION TAKING EPIDERMAL SERINE RACEMASE AND/OR D-SERINE LEVEL AS INDICATOR

#6
20200208194
2020-07-02

COAGULATION AND FIBRINOLYSIS ASSAYS

#7
20190300953
2019-10-03

Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator

#8
20180043015
2018-02-15

Methods for diagnosing and reducing incidences of cardiac allograft rejection

#9
20170108510
2017-04-20

A-fucosylation detection in antibodies

#10
20170073751
2017-03-16

Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator

#11
20160251356
2016-09-01

Fluorescent carbapenems

#12
20160069888
2016-03-10

METHOD FOR THE DIAGNOSTIC OF CANCER AND ENZYME-LINKED IMMUNOASSAY (ELISA) KIT FOR ITS APPLICATION

#13
20130102017
2013-04-25

Fluorescent carbapenems

#14
20130102008
2013-04-25

Method for screening for S1P lyase inhibitors using cultured cells

#15
20120244559
2012-09-27

Nanobeads covered with plasminogen as a direct support for cyclic amplification of the prion protein PrP

#16
20120196310
2012-08-02

A-FUCOSYLATION DETECTION IN ANTIBODIES

#17
20120082677
2012-04-05

COMPOSITIONS FOR THE TREATMENT OF HCV AND HBV

#18
20120009595
2012-01-12

Binding of aggregated forms of proteins

#19
20110318770
2011-12-29

COMPOSITIONS, KITS AND METHODS FOR DETERMINING PLASMIN ACTIVITY

#20
20100286053
2010-11-11

PLASMINOGEN ACTIVATOR INHIBITOR AMELIORATION OF NEWBORN HYPOXIC ISCHEMIC BRAIN INJURY

#21
20100184054
2010-07-22

Binding of pathological forms of prion proteins

#22
20090176258
2009-07-09

TEST FOR THE DETECTION OF PATHOLOGICAL PRIONS

#23
20090136967
2009-05-28

Peptides for discrimination of prions

#24
20090104690
2009-04-23

DEVICE FOR DETECTING AN ENZYME IN A SAMPLE

#25
20090068682
2009-03-12

Immunological assay for plasmin-digested products of stabilized fibrin

#26
20080096221
2008-04-24

Method of detecting platelet thrombosis or organ failure

#27
20070065923
2007-03-22

Peptides for discrimination of prions

#28
20060188929
2006-08-24

Method capable of being automated for detection of prpres and uses thereof

#29
20060094071
2006-05-04

Method for enriching and tracking pathologic modified prions-proteins(prpsc)

#30
20050221404
2005-10-06

Binding of pathological forms of prion proteins

#31
20050009131
2005-01-13

Method for determining the biological activity of defibrotide